2010•Cochrane Database of Systematic ReviewsRequires access

Paliperidone palmitate for schizophrenia

Abraham M. Nussbaum, T. Scott Stroup

Open publisher page 2 citations

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the efficacy, adverse effects and safety of paliperidone palmitate with any other treatment, including placebo, for people with schizophrenia and schizophrenia‐like illnesses.

About this research paper

What this paper is about

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the efficacy, adverse effects and safety of paliperidone palmitate with any other treatment, including placebo, for people with schizophrenia and schizophrenia‐like illnesses.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the efficacy, adverse effects and safety of paliperidone palmitate with any other treatment, including placebo, for people with schizophrenia and schizophrenia‐like illnesses.

Key concepts: Paliperidone Palmitate, Schizophrenia (object-oriented programming), Paliperidone, Placebo, Adverse effect, Medicine, Psychiatry, Protocol (science)

Related papers

Back to paper searchBrowse research topicsOriginal source
Paliperidone palmitate for schizophrenia — Research Paper | ScholarLens